Floatz logo

Pioglitazone

Friedreich's Ataxia

Assistance Publique - Hôpitaux de ParisSmall moleculePhase 3Dormant
B
63/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
48/ 100
Competitive Position
95/ 100

Competitive context

16 Active assets in the Friedreich's Ataxia cohort.

Asset / SponsorPhaseRating
Idebenone
Santhera Pharmaceuticals
Phase 3A
Interferon Γ-1B
Amgen
Phase 3BB
Omaveloxolone
Biogen
Phase 3BB
rt001
Biojiva LLC
Phase 3BB
Trans-Resveratrol
Murdoch Childrens Research Institute
Phase 2BB

View all 38 →

Same molecule, other indications

Pioglitazone is also rated in:

diabetes mellitusDormant
BBB
Indicative ·
79 / 100
View asset →
metabolic dysfunction-associated steatohepatitisDormant
BBB
Indicative ·
75 / 100
View asset →
abdominal obesity-metabolic syndromeDormant
BBB
Indicative ·
73 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →